Upcoming Webinar: CanPath Data Harmonization
Are you working with multi-regional data? 🗺️ Learn how Maelstrom Research tackles data harmonization using CanPath as a case study. 📅 June 10 | 🕐 1 PM EDT 🔗 Register >> us02web.zoom.us/webinar/regi…
Are you working with multi-regional data? 🗺️ Learn how Maelstrom Research tackles data harmonization using CanPath as a case study. 📅 June 10 | 🕐 1 PM EDT 🔗 Register >> us02web.zoom.us/webinar/regi…
“Data save lives. It’s as simple as that.” 👏 Thank you to the Canadian Cancer Society for having CanPath at the Cancer Data Community of Practice Workshop in Toronto this March. We were honoured to join this important conversation about improving Canada’s cancer data ecosystem because better data means better outcomes for all Canadians. Dr. Read more about Canadian Cancer Society – Data Saves Lives[…]
Breast cancer is one of the most common cancers and the second leading cause of cancer-related death among women* in Canada, with one in eight women expected to be diagnosed in their lifetime. Early detection through screening can make treatment easier and improve survival rates. In April 2024, the US recommended starting breast cancer screening for Read more about Government of Canada invests in breast cancer research at CanPath[…]
FOR IMMEDIATE RELEASE – Wednesday, June 5, 2024 Predicting chronic disease enabled by New Brunswick and Nova Scotia data linkage Predicting chronic disease has gotten faster and simpler with the linkage of data gathered from a longitudinal study involving over 34,000 participants and administrative health data routinely gathered by New Brunswick and Nova Scotia. Read more about Predicting chronic disease enabled by New Brunswick and Nova Scotia data linkage[…]
Using CanPath to Support Innovative Health Research Join our colleagues, Dr. Parveen Bhatti (Scientific Director, BC Generations) and Sheraz Cheema (Data Manager, CanPath) on Wednesday, October 11th to learn about CanPath, types of questions the data can be used to address, and how the data can be accessed. Registration: https://t.co/m8PU92M881
CanPath and its regional cohorts, including Atlantic PATH, are proud to be part of the COVID-19 Immunity Task Force (CITF) Databank with our COVID-19 serology study that includes participants across the country. The CITF Databank data holdings include data from 21 studies, including six multi-province studies “representing a wide range of population and community data from Read more about CITF COVID-19 Immunity Task Force Databank[…]
Join the CanPath team as the new Research Operations Manager at the University of Toronto. Deadline: September 22, 2023. “CanPath is Canada’s largest population health cohort and a national platform for population-level health research. CanPath is studying the biology, behaviours and environments of Canadians to learn more about the causes of chronic disease and cancer Read more about CanPath is Hiring: Research Operations Manager[…]
The CanPath team was well represented at the Canadian Society for Epidemiology & Biostatistics (CSEB) Conference in Halifax on June 26-28, 2023. We had representatives from the CanPath National Coordinating Centre, Atlantic PATH, CARTaGENE, the Manitoba Tomorrow Project, and the Ontario Health Study that showcased the groundbreaking research and resources available related to epidemiology and biostatistics within CanPath and the regional cohorts. Read more about CSEB Conference Update[…]
Congratulations to Kalli Hood and team on their new publication in Frontiers in Public Health! Kalli’s Master’s research found an association between a history of cancer and arsenic speciation/metallome exposure in the Atlantic PATH cohort. This work is part of our larger focus on environment and cancer, and establishing toenails as an important biomarker representing Read more about New Toxicology Publication[…]
Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: Read more about Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19[…]